RNAimmune

RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines. RNAimmune is backed by investors that include Terra Magnum Capital Partners (“TMCP”) and is headquartered in Gaithersburg.